Gérard Vergoten

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Protein Protein

Urinary Tract Infection

Candida Albicans

Top Venues

Molecules (Basel, Switzerland)

Journal of biomolecular structure & dynamics

Journal of biochemical and molecular toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Bailly, Gérard Vergoten
Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Christian Bailly, Gérard Vergoten
Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Maria Jozefa Bouckaert, René Roy
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15 (2) (2023)
Christian Bailly, Gérard Vergoten
Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Maria Jozefa Bouckaert, René Roy
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15 (2) (2023)
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Maria Jozefa Bouckaert, René Roy
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15 (2) (2023)
Christian Bailly, Gérard Vergoten
Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study. Molecules (Basel, Switzerland) 28 (4) (2023)
Leila Mousavifar, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Maria Jozefa Bouckaert, René Roy
Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 15 (2) (2023)
Gérard Vergoten, Christian Bailly
Molecular docking study of GSK-3β interaction with nomilin, kihadanin B, and related limonoids and triterpenes with a furyl-δ-lactone core. Journal of biochemical and molecular toxicology 36 (9) (2022)
Gérard Vergoten, Christian Bailly
Interaction of panduratin A and derivatives with the SARS-CoV-2 main protease (m pro ): a molecular docking study. Journal of biomolecular structure & dynamics (2022)